|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenues | |
| Expenses | |
| Research and development | |
| General and administrative | |
| Marketing | |
| Share-based payments | |
| Total expenses | |
| Other items | |
| Amortization and depreciation | |
| Net financial (income) expense | |
| Other items | |
| Net loss | |
| Other comprehensive income | |
| Gain on equity instrument designated at fair value through other comprehensive income | |
| Total comprehensive loss | |
| Basic loss per share | |
| Diluted loss per share | |
| Weighted average number of common shares, basic | |
| Weighted average number of common shares, diluted |
Loading...
